Rachel Giles, MD, PhD, describes her patient data on adjuvant and first line treatments in renal cell carcinoma.
Dr. Giles is the Chief Executive Officer of the International Kidney Cancer Coalition.
Rachel Giles, MD, PhD, describes her patient data on adjuvant and first line treatments in renal cell carcinoma.
Dr. Giles is the Chief Executive Officer of the International Kidney Cancer Coalition.